Ildiko Lingvay

81PUBLICATIONS
167CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedPharmacogenomicsSolid tumoursGastroenterology and hepatologyEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (81)

|Jun 24, 2026
Publisher Correction: Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial.

|Jun 05, 2026
Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial.

|Apr 20, 2026
Hyperaldosteronism in the Pathophysiology and Management of Cardiovascular-Kidney-Metabolic Syndrome.

|Apr 02, 2026
Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trial.

Sebastian M Meyhöfer, Bertrand Cariou, Cintia Cercato

|Mar 27, 2026
Safety of Semaglutide After Dialysis Initiation: An Individual-Level Pooled Analysis.

Klara R Klein, Anna Menacher, John B Buse

|Mar 20, 2026
Type 2 diabetes mellitus.

Melanie J Davies, Soo Lim, Tommy Slater

Pageof 14

Frequent Collaborators

10 joint publications

Julio Rosenstock

5 joint publications

Melanie J Davies

5 joint publications

Harpreet S Bajaj

4 joint publications

Robert F Kushner